Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2015

Open Access 01-12-2015 | Research article

Folic acid supplementation, preconception body mass index, and preterm delivery: findings from the preconception cohort data in a Chinese rural population

Authors: Yuanyuan Wang, Zongfu Cao, Zuoqi Peng, Xiaona Xin, Ya Zhang, Ying Yang, Yuan He, Jihong Xu, Xu Ma

Published in: BMC Pregnancy and Childbirth | Issue 1/2015

Login to get access

Abstract

Background

Folic acid (FA) supplementation before and during the first trimester can reduce the risk of occurrence of preterm delivery (PTD). Preconception body mass index (BMI) is also associated with PTD. This study aimed to investigate the combined effect of FA supplements and preconception BMI on the risk of PTD.

Methods

The data of a cohort from 2010–2011 that was obtained through a preconception care service in China was used (including 172,206 women). A multivariable regression model was used to investigate the association between maternal preconception conditions and the risk of PTD. The interaction of preconception BMI and FA supplementation was measured by a logistic regression model.

Results

Taking FA supplements in the preconception period or in the first trimester reduced the risk of PTD (odds ratio [OR] = 0.58 and OR = 0.61, respectively). Women with an abnormal BMI had an increased risk of PTD (OR = 1.09, OR = 1.10, and OR = 1.17 for underweight, overweight, and obese, respectively). Preconception BMI showed an interaction with the protective effect of FA supplementation for PTD. With regard to the interaction of FA supplementation, the adjusted odds ratio (aOR) was 0.57 (95 % CI: 0.51, 0.64) in underweight women, 0.85 (95 % CI: 0.73, 0.98) in overweight women, and 0.77 (95 % CI, 0.65, 0.91) in obese women. Preconception BMI also showed an interaction with the time of FA supplementation. Women with a normal BMI who began to take FA supplements in the preconception period had the lowest risk of PTD (aORs: 0.58 vs. 0.65 beginning in the first trimester). The aORs at preconception and the first trimester in the underweight group were 0.56 vs. 0.60. The aORs at preconception and the first trimester were 0.94 vs. 0.65 and 1.15 vs. 0.60 in the overweight and obesity groups, respectively.

Conclusions

In our study, FA supplements reduced the risk of PTD, while abnormal BMI raised the risk of PTD, although higher BMI categories did not have this higher risk once adjusted analysis was conducted. The protective effect of FA supplementation for PTD was reduced in women with overweight or obesity. To get better protection of FA supplementation, women with normal BMI or underweight should begin to use in preconception, while women with overweight or obesity should begin to use after conception.
Literature
1.
Gravett MG, Rubens CE. Global Alliance to Prevent Prematurity and Stillbirth Technical Team: A framework for strategic investments in research to reduce the global burden of preterm birth. Am J Obstet Gynecol. 2012;207:368–73.CrossRefPubMed
2.
Liang J, Mao M, Dai L, Li X, Miao L, Li Q, et al. Neonatal mortality due to preterm birth at 28–36 weeks’ gestation in China, 2003–2008. Paediatr Perinat Epidemiol. 2011;25:593–600.CrossRefPubMed
3.
Werler MM, Shapiro S, Mitchell AA. Mitchell, Periconceptional folic acid exposure and risk of occurrent neural tube defects. Jama. 1993;269:1257–61.CrossRefPubMed
4.
Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219–26.CrossRefPubMed
5.
Rozendaal AM, van Essen AJ, te Meerman GJ, Bakker MK, van der Biezen JJ, Goorhuis-Brouwer SM, et al. Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case–control study. Eur J Epidemiol. 2013;28:875–87.CrossRefPubMed
6.
Li Z, Ye R, Zhang L, Li H, Liu J, Ren A. Periconceptional folic acid supplementation and the risk of preterm births in China: a large prospective cohort study. Int J Epidemiol. 2014;43:1132–9.CrossRefPubMedPubMedCentral
7.
Czeizel AE, Puhó EH, Langmar Z, Acs N, Bánhidy F. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur J Obstet Gynecol Reprod Biol. 2010;148:135–40.CrossRefPubMed
8.
Naimi AI, Auger N. Population-wide folic acid fortification and preterm birth: testing the folate depletion hypothesis. Am J Public Health. 2015;105(4):793–5.CrossRefPubMed
9.
Papadopoulou E, Stratakis N, Roumeliotaki T, Sarri K, Merlo DF, Kogevinas M, et al. The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). Eur J Nutr. 2013;52:327–36.CrossRefPubMed
10.
Dunlop AL, Taylor RN, Tangpricha V, Fortunato S, Menon R. Maternal micronutrient status and preterm versus term birth for black and white US women. Reprod Sci. 2012;19:939–48.CrossRefPubMedPubMedCentral
11.
Yamada T, Morikawa M, Yamada T, Kishi R, Sengoku K, Endo T, et al. First-trimester serum folate levels and subsequent risk of abortion and preterm birth among Japanese women with singleton pregnancies. Arch Gynecol Obstet. 2013;287:9–14.CrossRefPubMed
12.
Naimi AI, Auger N. Population-wide folic acid fortification and preterm birth: testing the folate depletion hypothesis. Am J Public Health. 2015;105:793–5.CrossRefPubMed
13.
Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013;3:CD006896.PubMed
14.
Bakker R, Timmermans S, Steegers EA, Hofman A, Jaddoe VW. Folic acid supplements modify the adverse effects of maternal smoking on fetal growth and neonatal complications. J Nutr. 2011;141:2172–9.CrossRefPubMed
15.
Shah R, Mullany LC, Darmstadt GL, Mannan I, Rahman SM, Talukder RR, et al. Incidence and risk factors of preterm birth in a rural Bangladeshi cohort. BMC Pediatr. 2014;14:112.CrossRefPubMedPubMedCentral
16.
Chen LW, Lim AL, Colega M, Tint MT, Aris IM, Tan CS, et al. Maternal folate status, but not that of vitamins B-12 or B-6, is associated with gestational age and preterm birth risk in a multiethnic Asian population. J Nutr. 2015;145:113–20.CrossRefPubMed
17.
Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr. 1996;63:520–5.PubMed
18.
Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A. Second trimester folate status and preterm birth. Am J Obstet Gynecol. 2004;191:1851–7.CrossRefPubMed
19.
Zhao M, Chen YH, Dong XT, Zhou J, Chen X, Wang H, et al. Xu DX Folic acid protects against lipopolysaccharide-induced preterm delivery and intrauterine growth restriction through its anti-inflammatory effect in mice. PLoS One. 2013;8:e82713.CrossRefPubMedPubMedCentral
20.
Kim H, Hwang JY, Ha EH, Park H, Ha M, Lee SJ, et al. Association of maternal folate nutrition and serum C-reactive protein concentrations with gestational age at delivery. Eur J Clin Nutr. 2011;65:350–6.CrossRefPubMed
21.
Simhan HN, Himes KP, Venkataramanan R, Bodnar LM. Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu. Am J Obstet Gynecol. 2011;205(61):e1–7.PubMed
22.
Dhobale M, Chavan P, Kulkarni A, Mehendale S, Pisal H, Joshi S. Reduced folate, increased vitamin B(12) and homocysteine concentrations in women delivering preterm. Ann Nutr Metab. 2012;61:7–14.CrossRefPubMed
23.
Kim MW, Hong SC, Choi JS, Han JY, Oh MJ, Kim HJ, et al. folate and pregnancy outcomes. J Obstet Gynaecol. 2012;32:520–4.CrossRefPubMed
24.
Papachatzi E, Dimitriou G, Dimitropoulos K, Vantarakis A. Pre-pregnancy obesity: maternal, neonatal and childhood outcomes. J Neonatal Perinatal Med. 2013;6:203–16.PubMed
25.
Lynch AM, Hart JE, Agwu OC, Fisher BM, West NA, Gibbs RS. Association of extremes of prepregnancy BMI with the clinical presentations of preterm birth. Am J Obstet Gynecol. 2014;210(428):e1–9.PubMed
26.
27.
Fujiwara K, Aoki S, Kurasawa K, Okuda M, Takahashi T, Hirahara F. Associations of maternal pre-pregnancy underweight with small-for-gestational-age and spontaneous preterm birth, and optimal gestational weight gain in Japanese women. J Obstet Gynaecol Res. 2014;40:988–94.CrossRefPubMed
28.
Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large-for-gestational-age infants. J Matern Fetal Neonatal Med. 2015;28:1679–86.CrossRefPubMed
29.
Parker MG, Ouyang F, Pearson C, Gillman MW, Belfort MB, Hong X, et al. Prepregnancy body mass index and risk of preterm birth: association heterogeneity by preterm subgroups. BMC Pregnancy Childbirth. 2014;14:153.CrossRefPubMedPubMedCentral
30.
Shaw GM, Carmichael SL, Yang W. Siega-Riz AM; National Birth Defects Prevention Study: Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am J Perinatol. 2011;28:747–52.CrossRefPubMed
31.
Tinker SC, Hamner HC, Berry RJ, Bailey LB, Pfeiffer CM. Does obesity modify the association of supplemental folic acid with folate status among nonpregnant women of childbearing age in the United States? Birth Defects Res A Clin Mol Teratol. 2012;94:749–55.CrossRefPubMed
32.
Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol. 2004;19(11):1029–36.CrossRefPubMed
33.
da Silva VR, Hausman DB, Kauwell GP, Sokolow A, Tackett RL, Rathbun SL, et al. Obesity affects short-term folate pharmacokinetics in women of childbearing age. Int J Obes (Lond). 2013;37:1608–10.CrossRef
34.
Kim H, Hwang JY, Kim KN, Ha EH, Park H, Ha M, et al. Relationship between body-mass index and serum folate concentrations in pregnant women. Eur J Clin Nutr. 2012;66:136–8.CrossRefPubMed
35.
Stern SJ, Matok I, Kapur B, Koren G. Dosage requirements for periconceptional folic acid supplementation: accounting for BMI and lean body weight. J Obstet Gynaecol Can. 2012;34:374–8.CrossRefPubMed
36.
Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, et al. Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada and The Motherrisk Program: Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:1003–26.CrossRefPubMed
37.
38.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.CrossRefPubMed
39.
40.
Chen C, Lu FC, Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.PubMed
41.
Rothman K, Greenland S, Lash T, editors. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.
42.
Liu J, Jin L, Meng Q, Gao L, Zhang L, Li Z, et al. Changes in folic acid supplementation behaviour among women of reproductive age after the implementation of a massive supplementation programme in China. Public Health Nutr. 2015;18:582–8.CrossRefPubMed
43.
Mantovani E, Filippini F, Bortolus R, Franchi M. Folic acid supplementation and preterm birth: results from observational studies. Biomed Res Int. 2014;2014:481914.CrossRefPubMedPubMedCentral
44.
Sengpiel V, Bacelis J, Myhre R, Myking S, Devold Pay AS, Haugen M, et al. Folic acid supplementation, dietary folate intake during pregnancy and risk for spontaneous preterm delivery: a prospective observational cohort study. BMC Pregnancy Childbirth. 2014;14:375.CrossRefPubMedPubMedCentral
45.
Johnson TS, Rottier KJ, Luellwitz A, Kirby RS. Maternal prepregnancy body mass index and delivery of a preterm infant in Missouri 1998–2000. Public Health Nurs. 2009;26:3–13.CrossRefPubMed
46.
Mandal D, Manda S, Rakshi A, Dey RP, Biswas SC, Banerjee A. Maternal obesity and pregnancy outcome: a prospective analysis. J Assoc Physicians India. 2011;59:486–9.PubMed
47.
Sukla KK, Tiwari PK, Kumar A, Raman R. Low birthweight (LBW) and neonatal hyperbilirubinemia (NNH) in an Indian cohort: association of homocysteine, its metabolic pathway genes and micronutrients as risk factors. PLoS One. 2013;8:e71587.CrossRefPubMedPubMedCentral
48.
Goldberg BB, Alvarado S, Chavez C, Chen BH, Dick LM, Felix RJ, et al. Teratogen Information Service: Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A Clin Mol Teratol. 2006;76:193–9.CrossRefPubMed
49.
Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology. 1996;7:507–12.CrossRefPubMed
50.
Bird JK, Ronnenberg AG, Choi SW, Du F, Mason JB, Liu Z. Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations. J Nutr. 2015;145(1):79–86.CrossRefPubMed
51.
Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J, Russcher H, et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG. 2012;119:739–51.CrossRefPubMed
52.
Wang M, Wang ZP, Gao LJ, Gong R, Sun XH, Zhao ZT. Maternal body mass index and the association between folic acid supplements and neural tube defects. Acta Paediatr. 2013;102:908–13.CrossRefPubMed
53.
Xing XY, Tao FB, Hao JH, Huang K, Huang ZH, Zhu XM, et al. Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study. Midwifery. 2012;28:291–7.CrossRefPubMed
54.
Bukowski R, Malone FD, Porter FT, Nyberg DA, Comstock CH, Hankins GD, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med. 2009;6:e1000061.CrossRefPubMedPubMedCentral
Metadata
Title
Folic acid supplementation, preconception body mass index, and preterm delivery: findings from the preconception cohort data in a Chinese rural population
Authors
Yuanyuan Wang
Zongfu Cao
Zuoqi Peng
Xiaona Xin
Ya Zhang
Ying Yang
Yuan He
Jihong Xu
Xu Ma
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2015
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-015-0766-y

Other articles of this Issue 1/2015

BMC Pregnancy and Childbirth 1/2015 Go to the issue

Research article

Differences in pregnancy outcomes and characteristics between insulin- and diet-treated women with gestational diabetes

Research article

Unsafe abortion in Kenya: a cross-sectional study of abortion complication severity and associated factors

Research article

Validating the British Columbia Perinatal Data Registry: a chart re-abstraction study

Research article

Uterine artery Doppler in the management of early pregnancy loss: a prospective, longitudinal study

Research article

“My midwife said that having a glass of red wine was actually better for the baby”: a focus group study of women and their partner’s knowledge and experiences relating to alcohol consumption in pregnancy

Research article

Challenges and opportunities for implementing evidence-based antenatal care in Mozambique: a qualitative study